Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Trends in obesity-related cancer burden in Czechia

A. Altová

. 2023 ; 135 (5-6) : 134-141. [pub] 20220515

Language English Country Austria

Document type Journal Article

BACKGROUND AND OBJECTIVE: Obesity is a major lifestyle risk factor that contributes greatly to the burden of disease, including cancer. Overweight and obesity have shown association with several types of cancer. As Czechia is one of the most overweight countries in Europe, and has high cancer mortality, this study aims to investigate the country's long-term burden of obesity-related cancer. METHODS: Using the Czech National Cancer Register and the NCD Risk Factor Collaboration (NCD-RisC), standardized incidence and mortality rates were calculated for 12 types of cancer related to obesity for the years 1985-2018. Population attributable fractions (PAF) were calculated. Finally, the standardized attributable rates were calculated from the standardized incidence and mortality rates and the PAFs. RESULTS: Approximately 11.0% of selected cancer cases in the male population and 12.3% in the female population were attributable to overweight and obesity in 2018. Since the beginning of the millennium, obesity attributable cancer mortality has dropped, while incidence has remained constant. The incidence throughout the whole period was almost twice as high (18.7 cases per 100,000 population in 2018) in women than in men (10.9 cases per 100,000 population in 2018). CONCLUSION: Obesity-related cancer mortality in Czechia has declined in the last two decades, but the incidence has remained constant. Given the increasing prevalence of overweight and obesity in western countries, this issue needs to be prioritized in future healthcare and policy making.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23004066
003      
CZ-PrNML
005      
20230425141058.0
007      
ta
008      
230418s2023 au f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00508-022-02039-6 $2 doi
035    __
$a (PubMed)35569084
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a au
100    1_
$a Altová, Anna $u Department of Demography and Geodemography, Faculty of Science, Charles University, Albertov 6, 128 00, Prague 2, Czech Republic. anna.altova@natur.cuni.cz $1 https://orcid.org/000000027055889X
245    10
$a Trends in obesity-related cancer burden in Czechia / $c A. Altová
520    9_
$a BACKGROUND AND OBJECTIVE: Obesity is a major lifestyle risk factor that contributes greatly to the burden of disease, including cancer. Overweight and obesity have shown association with several types of cancer. As Czechia is one of the most overweight countries in Europe, and has high cancer mortality, this study aims to investigate the country's long-term burden of obesity-related cancer. METHODS: Using the Czech National Cancer Register and the NCD Risk Factor Collaboration (NCD-RisC), standardized incidence and mortality rates were calculated for 12 types of cancer related to obesity for the years 1985-2018. Population attributable fractions (PAF) were calculated. Finally, the standardized attributable rates were calculated from the standardized incidence and mortality rates and the PAFs. RESULTS: Approximately 11.0% of selected cancer cases in the male population and 12.3% in the female population were attributable to overweight and obesity in 2018. Since the beginning of the millennium, obesity attributable cancer mortality has dropped, while incidence has remained constant. The incidence throughout the whole period was almost twice as high (18.7 cases per 100,000 population in 2018) in women than in men (10.9 cases per 100,000 population in 2018). CONCLUSION: Obesity-related cancer mortality in Czechia has declined in the last two decades, but the incidence has remained constant. Given the increasing prevalence of overweight and obesity in western countries, this issue needs to be prioritized in future healthcare and policy making.
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a nadváha $x epidemiologie $7 D050177
650    12
$a neinfekční nemoci $7 D000073296
650    _2
$a obezita $x epidemiologie $7 D009765
650    _2
$a rizikové faktory $7 D012307
650    12
$a nádory $x epidemiologie $7 D009369
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
773    0_
$w MED00010762 $t Wiener klinische Wochenschrift $x 1613-7671 $g Roč. 135, č. 5-6 (2023), s. 134-141
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35569084 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425141054 $b ABA008
999    __
$a ok $b bmc $g 1924625 $s 1190275
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 135 $c 5-6 $d 134-141 $e 20220515 $i 1613-7671 $m Wiener klinische Wochenschrift $n Wien Klin Wochenschr $x MED00010762
LZP    __
$a Pubmed-20230418

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...